Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression
Author:
Affiliation:
1. Oncology Department; ASO Santa Croce e Carle Cuneo; Cuneo Italy
Publisher
Wiley
Subject
Otorhinolaryngology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.25418/fullpdf
Reference17 articles.
1. The secret ally: immunostimulation by anticancer drugs;Galluzzi;Nat Rev Drug Discov,2012
2. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;Ferris;N Engl J Med,2016
3. Second-line chemotherapy in head and neck cancer: what should we expect?;Büntzel;Expert Rev Anticancer Ther,2009
4. Treatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 CheckMate 141 study: a biomarker analysis and updated clinical outcomes;Haddad;Ann Oncol,2017
5. Progression beyond nivolumab: stop or repeat? Dramatic responses with salvage chemotherapy;Daste;Oral Oncol,2018
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Major and durable responses to photon and electron-beam palliative radiotherapies after immune-checkpoint inhibitors in head and neck cancer;Oral Oncology;2024-03
2. Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma;Biomedicines;2023-10-25
3. Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer;Anti-Cancer Drugs;2022-11-17
4. How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review;Biomedicines;2022-07-28
5. Unexpected response to fourth-line paclitaxel in a patient with metastatic oropharyngeal squamous cell carcinoma, immunotherapy-refractory: a case report;Anti-Cancer Drugs;2022-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3